Vivos (RDGL) FCF Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Vivos (RDGL) FCF Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 884.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 503.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 646.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 534.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 919.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 3,472.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 353.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -97.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 60.00 |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 215,417.00 |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | -240,036.00 |
| Mar 31, 2025 | 125,434.00 |
| Sep 30, 2024 | -892,894.00 |
| Sep 30, 2023 | -54,289.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | -204,140.00 |
| Sep 30, 2019 | -7.96 Mn |
| Mar 31, 2018 | 190,911.00 |
| Mar 31, 2017 | -382,541.00 |
| Sep 30, 2016 | 7.76 Mn |
| Mar 31, 2016 | -1.19 Mn |
| Sep 30, 2015 | -9,429.00 |
| Mar 31, 2015 | -176,829.00 |
| Jun 30, 2014 | -315,877.00 |
| Mar 31, 2014 | -294,548.00 |
| Sep 30, 2013 | -1,947.00 |